What was Interpharm Holdings’s price range in the past 12 months?
Interpharm Holdings lowest stock price was $0.00 and its highest was $0.01 in the past 12 months.
What is Interpharm Holdings’s market cap?
Interpharm Holdings’s market cap is $67.
When is Interpharm Holdings’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
Is Interpharm Holdings overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Interpharm Holdings pay dividends?
Interpharm Holdings does not currently pay dividends.
What is Interpharm Holdings’s EPS estimate?
Interpharm Holdings’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Interpharm Holdings have?
Interpharm Holdings has 66,738,430 shares outstanding.
Which hedge fund is a major shareholder of Interpharm Holdings?
Currently, no hedge funds are holding shares in IPAH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Interpharm Holdings
Interpharm Holdings, Inc. specializes in the formulation, manufacturing, and commercialization of generic pharmaceuticals, encompassing both prescription-strength and over-the-counter varieties. The company's medicinal products are supplied to a wide array of clients, including significant retail chains, wholesale distributors, managed healthcare organizations, and nationwide distribution networks. Established in 1984, the firm maintains its principal operations in Hauppauge, New York.